Skip to main content

Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 676–690 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-6337
SLC5A1 Gene Glucose/Galactose Malabsorption Genetic Test

This test identifies pathogenic variants in the SLC5A1 gene, which are the cause of glucose/galactose malabsorption (GGM). It provides a definitive molecular diagnosis for this rar...

Whole Blood, Extracted DNA, or FTA Card 3–4 weeks from sample collection 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC5A1 gene", "Copy Number Variations (CNVs) in the SLC5A1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant medications"]
Indications
["Suspected glucose/galactose malabsorption (GGM)", "Severe neonatal diarrhea unresponsive to standard treatment", "Family history of GGM"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94027-2 ICD-10: E74.39
Clinical summary
This test identifies pathogenic variants in the SLC5A1 gene, which are the cause of glucose/galactose malabsorption (GGM). It provides a definitive molecular diagnosis for this rare inherited disorder.
TEST-3471
SLC5A5 Gene Thyroid Dyshormonogenesis Type 1 Genetic Test

This genetic test evaluates the SLC5A5 gene for pathogenic variants associated with thyroid dyshormonogenesis type 1, an iodide transport defect.

Peripheral blood (whole blood in EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC5A5 gene", "Iodide transport defect"]
Parameters
[]
Preparation
[]
Indications
["Congenital hypothyroidism of unknown etiology", "Low radioiodine uptake"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 96728-9 ICD-10: E07.1
Clinical summary
This genetic test evaluates the SLC5A5 gene for pathogenic variants associated with thyroid dyshormonogenesis type 1, an iodide transport defect.
TEST-3654
SLC7A7 Gene Lysinuric Protein Intolerance Genetic Test

This genetic test evaluates the SLC7A7 gene for pathogenic variants associated with Lysinuric Protein Intolerance (LPI).

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC7A7 gene", "Point mutations", "Small insertions/deletions", "Copy number variations (CNV)"]
Parameters
[]
Preparation
["No fasting required", "Provide details of any previous metabolic investigations", "Mandatory comprehensive clinical history and pedigree charting by a certified genetic counselor before blood collection"]
Indications
["Suspected diagnosis of Lysinuric Protein Intolerance (LPI)", "Family screening for carriers of SLC7A7 mutations", "Differential diagnosis of aminoacidurias or mitochondrial hepatopathies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E72.2
Clinical summary
This genetic test evaluates the SLC7A7 gene for pathogenic variants associated with Lysinuric Protein Intolerance (LPI).
TEST-4777
SLC9A3R1 Gene Analysis for Nephrolithiasis/Osteoporosis, Hypophosphatemic Type 2 Test

This diagnostic test evaluates the SLC9A3R1 gene for pathogenic variants associated with hereditary hypophosphatemic nephrolithiasis, osteoporosis, and renal phosphate wasting.

Peripheral whole blood (EDTA tube, 5 mL) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC9A3R1 gene"]
Parameters
[]
Preparation
["Mandatory genetic counselling session", "No fasting required"]
Indications
["Diagnosis of hereditary hypophosphatemic nephrolithiasis", "Diagnosis of hereditary osteoporosis", "Family screening for SLC9A3R1-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E83.31, N20.0
Clinical summary
This diagnostic test evaluates the SLC9A3R1 gene for pathogenic variants associated with hereditary hypophosphatemic nephrolithiasis, osteoporosis, and renal phosphate wasting.
TEST-3668
SLC9A3R1 Genetic Test (Nephrolithiasis/Osteoporosis, Hypophosphatemic Type 2)

This diagnostic test evaluates for pathogenic variants in the SLC9A3R1 gene associated with autosomal recessive nephrolithiasis/osteoporosis, hypophosphatemic type 2.

Peripheral whole blood or extracted DNA (EDTA tube) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SLC9A3R1 gene"]
Parameters
[]
Preparation
["No fasting required", "Provide a blood sample (EDTA tube) or previously extracted DNA", "Mandatory genetic counseling session required"]
Indications
["Suspected autosomal recessive nephrolithiasis/osteoporosis, hypophosphatemic type 2", "Family history of the condition"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 47527-7 ICD-10: E83.39
Clinical summary
This diagnostic test evaluates for pathogenic variants in the SLC9A3R1 gene associated with autosomal recessive nephrolithiasis/osteoporosis, hypophosphatemic type 2.
TEST-3749
SLCO1B1 Gene Rotor‑type Hyperbilirubinemia Genetic Test

This genetic test identifies pathogenic variants in the SLCO1B1 gene associated with Rotor syndrome.

Whole blood (EDTA), dried blood spot (FTA card), or extracted DNA 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLCO1B1 gene variants", "Single nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
[]
Indications
["Confirm hereditary Rotor syndrome", "Differentiate from other conjugated hyperbilirubinemias"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E80.6
Clinical summary
This genetic test identifies pathogenic variants in the SLCO1B1 gene associated with Rotor syndrome.
TEST-3791
SLCO1B3 Gene Hyperbilirubinemia (Rotor Type) Genetic Test

This genetic test identifies mutations in the SLCO1B3 gene associated with Rotor syndrome, a hereditary cause of conjugated hyperbilirubinemia.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLCO1B3 gene mutations", "SLCO1B1 gene mutations"]
Parameters
[]
Preparation
["No fasting required"]
Indications
["Suspected Rotor syndrome", "Unexplained conjugated hyperbilirubinemia", "Family history of Rotor syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 77735-7 ICD-10: E80.6, Z15.89, R17
Clinical summary
This genetic test identifies mutations in the SLCO1B3 gene associated with Rotor syndrome, a hereditary cause of conjugated hyperbilirubinemia.
TEST-5034
SLCO2A1 Gene Hypertrophic Osteoarthropathy Type 2 Genetic Test

This genetic test identifies pathogenic variants in the SLCO2A1 gene associated with primary hypertrophic osteoarthropathy type 2.

Peripheral whole blood, FTA card, or pre-extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SLCO2A1 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Suspected primary hypertrophic osteoarthropathy type 2", "Family history of PHOAR2", "Differential diagnosis of clubbing and bone pain"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76002-6 ICD-10: M89.40
Clinical summary
This genetic test identifies pathogenic variants in the SLCO2A1 gene associated with primary hypertrophic osteoarthropathy type 2.
TEST-4819
SMAD3 Gene (Loeys‑Dietz Syndrome Type 1C) Genetic Test

This genetic test identifies pathogenic variants in the SMAD3 gene associated with Loeys‑Dietz syndrome type 1C.

Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SMAD3 gene"]
Parameters
[]
Preparation
["Complete clinical history form", "Genetic counseling session recommended"]
Indications
["Suspected Loeys‑Dietz syndrome type 1C", "Family history of Loeys‑Dietz syndrome", "Confirmation of clinical diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q87.89
Clinical summary
This genetic test identifies pathogenic variants in the SMAD3 gene associated with Loeys‑Dietz syndrome type 1C.
TEST-5297
SMC3 Gene (Cornelia de Lange Syndrome Type 3) Genetic Test

This diagnostic test evaluates the SMC3 gene for pathogenic variants associated with Cornelia de Lange syndrome type 3.

Peripheral whole blood (EDTA) or Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SMC3 gene", "Single nucleotide variants (SNVs)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Inform physician about current medications"]
Indications
["Clinical signs suggestive of Cornelia de Lange syndrome type 3", "Need for definitive molecular diagnosis for management", "Family planning considerations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60567-5 ICD-10: Q87.1
Clinical summary
This diagnostic test evaluates the SMC3 gene for pathogenic variants associated with Cornelia de Lange syndrome type 3.
TEST-5520
SNCA Gene (PARK4) Parkinson Genetic Test

This test evaluates the SNCA gene for pathogenic variants associated with autosomal dominant Parkinson's disease.

Peripheral whole blood, Extracted DNA, FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SNCA gene coding region"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Individuals with clinical features suggestive of autosomal dominant Parkinson's disease", "Family members of individuals with known SNCA pathogenic variants"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 80560-6 ICD-10: G20
Clinical summary
This test evaluates the SNCA gene for pathogenic variants associated with autosomal dominant Parkinson's disease.
TEST-4993
SNRPE Gene Hypotrichosis Type 11 Genetic Test

This test identifies pathogenic variants within the SNRPE gene associated with hereditary hypotrichosis type 11 using Next Generation Sequencing.

Whole Blood, Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SNRPE gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"]
Parameters
[]
Preparation
["Pre-test genetic counseling session recommended", "Construct a three-generation pedigree", "No fasting or special dietary preparation required", "Bring available medical records and family photographs"]
Indications
["Family history of hypotrichosis type 11", "Clinical suspicion of hypotrichosis type 11", "Confirmation of genetic etiology before therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94247-3 ICD-10: Q84.0
Clinical summary
This test identifies pathogenic variants within the SNRPE gene associated with hereditary hypotrichosis type 11 using Next Generation Sequencing.
TEST-3392
SOHLH1 Gene Oogenesis Dysfunction Genetic Test

This genetic test analyzes the SOHLH1 gene for variants associated with oogenesis dysfunction, primary ovarian insufficiency, and infertility.

Peripheral whole blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SOHLH1 gene variants", "Pathogenic mutations", "Novel variants"]
Parameters
[]
Preparation
[]
Indications
["Primary ovarian insufficiency", "Unexplained infertility"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94138-2 ICD-10: E28.3, N97.0
Clinical summary
This genetic test analyzes the SOHLH1 gene for variants associated with oogenesis dysfunction, primary ovarian insufficiency, and infertility.
TEST-2363
SOST Gene Sclerosteosis Type 1 Genetic Test

This genetic test evaluates the SOST gene for pathogenic variants associated with Sclerosteosis type 1.

Whole Blood (EDTA) or Dried Blood Spot (FTA Card) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SOST gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the phlebotomist about any medications"]
Indications
["Suspected Sclerosteosis type 1 based on clinical or radiological findings", "Family history of Sclerosteosis type 1", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33811-0 ICD-10: Q78.8
Clinical summary
This genetic test evaluates the SOST gene for pathogenic variants associated with Sclerosteosis type 1.
TEST-5088
SOX3 Gene Genetic Test

This test identifies pathogenic variants in the SOX3 gene associated with X-linked intellectual disability and isolated growth hormone deficiency.

Peripheral whole blood (EDTA) or dried blood spot (FTA card) 21–28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SOX3 gene", "Copy Number Variations (CNVs) in SOX3"]
Parameters
[]
Preparation
["No fasting required", "Continue all prescribed medications unless advised otherwise by a physician"]
Indications
["Individuals with clinical features suggestive of X-linked intellectual disability and isolated growth hormone deficiency", "Family history of SOX3-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81315-0 ICD-10: E23.0
Clinical summary
This test identifies pathogenic variants in the SOX3 gene associated with X-linked intellectual disability and isolated growth hormone deficiency.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.